Petco Director adds 20.6K shares via RSU grant – Form 4

Rhea-AI Filing Summary

Petco Health & Wellness Company, Inc. (WOOF) – Form 4 insider filing, 24 Jun 2025

Director Iris Yen reported the acquisition of 20,576 Class A common shares on 20 Jun 2025 at an indicated value of $2.47 per share (transaction code “A” indicates a stock grant/award, not an open-market purchase). Following the transaction, Yen’s direct ownership rose to 102,365 shares; an additional 1,983 shares are held indirectly through the Yen-Geniblazo Family Trust. The filing notes that 49,254 of the directly held shares are restricted stock units (RSUs) issued under the company’s 2021 equity plan, each convertible into one share upon vesting.

The grant increases the director’s total reported beneficial stake by roughly 25% versus pre-grant levels (derived from disclosed balances). While insider acquisitions can signal confidence, the use of RSU awards means the transaction reflects routine board compensation rather than discretionary buying. No sales were reported, and there are no accompanying derivative transactions. Overall, the filing modestly deepens insider alignment but is unlikely to be materially impactful to the company’s capital structure or trading dynamics given Petco’s ~300 million outstanding shares.

Insights

Financial Analyst

TL;DR: Routine RSU grant boosts director ownership; minimal market impact.

The transaction is a standard equity award: 20,576 shares granted at a reference price of $2.47, lifting Iris Yen’s direct stake to 102,365 shares. Because the A code denotes an award rather than an open-market purchase, the signal value is weaker than voluntary buying. Still, the absence of any concurrent sales keeps insider sentiment neutral-to-slightly positive. Relative to Petco’s float, the grant is immaterial (<0.01%), so valuation implications are negligible. Investors should view the filing as routine board compensation rather than a catalyst.

Insider Trade Summary

Net Buyer: 20,576 shares

Net Buy 2 txns

Insider Yen Iris

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	20,576	$2.47	$51K
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 102,365 shares (Direct); Class A Common Stock — 1,983 shares (Indirect, By Yen-Geniblazo Family Trust)

Footnotes (1)

1. F1. Includes 49,254 outstanding RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of Class A common stock of the Issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 06/24/2025 - 06:53 PM Learn about SEC filing dates

FAQ

How many Petco (WOOF) shares did Director Iris Yen acquire?

The Form 4 shows 20,576 Class A common shares were acquired on 20 Jun 2025.

Was the acquisition an open-market purchase?

No. The filing lists transaction code “A”, indicating a stock award or grant, not a market purchase.

What is Iris Yen’s total beneficial ownership after the grant?

Yen now directly owns 102,365 shares and indirectly owns 1,983 shares via a family trust.

Are restricted stock units (RSUs) included in the share count?

Yes. The footnote states 49,254 of the reported direct holdings are RSUs from the 2021 equity plan.

Does the Form 4 suggest a major impact on WOOF’s share count?

No. The grant represents <0.01% of shares outstanding, so dilution or market impact is negligible.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yen Iris

(Last) (First) (Middle)

C/O PETCO HEALTH AND WELLNESS COMPANY,

INC., 10850 VIA FRONTERA

(Street)

SAN DIEGO CA 92127

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Petco Health & Wellness Company, Inc. [ WOOF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/20/2025		A		20,576	A	$2.47	102,365(1)	D
Class A Common Stock								1,983	I	By Yen-Geniblazo Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 49,254 outstanding RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of Class A common stock of the Issuer.

	/s/ Giovanni Insana, as Attorney-in-Fact	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.